Page last updated: 2024-11-07

cannabidiolic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

cannabidiolic acid: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

cannabidiolic acid : A dihydroxybenzoic acid that is olivetolic acid in which the hydrogen at position 3 is substituted by a 3-p-mentha-1,8-dien-3-yl (limonene) group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID160570
CHEMBL ID498672
CHEBI ID3359
SCHEMBL ID141666
MeSH IDM0049703

Synonyms (32)

Synonym
1244-58-2
cannabidiolic acid
cbda
3-p-mentha-1,8-dien-3-yl-6-pentyl-beta-resorcylic acid
LMPK13120003
2,4-dihydroxy-3-[(1r,6r)-3-methyl-6-(prop-1-en-2-yl)cyclohex-2-en-1-yl]-6-pentylbenzoic acid
cannabidiol acid
chebi:3359 ,
CHEMBL498672 ,
bdbm50318485
2,4-dihydroxy-3-((1r,6r)-3-methyl-6-(prop-1-en-2-yl)cyclohex-2-enyl)-6-pentylbenzoic acid
2,4-dihydroxy-3-[(1r,6r)-3-methyl-6-prop-1-en-2-ylcyclohex-2-en-1-yl]-6-pentylbenzoic acid
fjx8o3ojcd ,
unii-fjx8o3ojcd
SCHEMBL141666
cannabidiolic acid [nflis-drug]
benzoic acid, 2,4-dihydroxy-3-((1r,6r)-3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl)-6-pentyl-
cannabidiolcarboxylic acid
DTXSID80154318 ,
WVOLTBSCXRRQFR-DLBZAZTESA-N
Q27106043
benzoic acid, 2,4-dihydroxy-3-[(1r,6r)-3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-6-pentyl-
cannabidiolic acid (cbda)
cannabidiolic acid (cbda) 100 microg/ml in acetonitrile
cannabidiolic acid (cbda) 1000 microg/ml in acetonitrile
gtpl10600
cannabidiolic acid (cbda) 250 microg/ml in acetonitrile
FS-10258
dtxcid8076809
cannabidiolic acid (nflis-drug)
2,4-dihydroxy-3-((1r,6r)-3-methyl-6-(prop-1-en-2-yl)cyclohex-2-en-1-yl)-6-pentylbenzoic acid
cannabidiolic acid (cbda), 1mg/ml in acetonitrile

Research Excerpts

Actions

ExcerptReferenceRelevance
"Cannabidiolic acid (CBDA) can activate peroxisome proliferator-activated receptor-α (PPARα) and PPARγ. "( Cannabidiolic acid activates the expression of the PPARβ/δ target genes in MDA-MB-231 cells.
Hirao-Suzuki, M; Peters, JM; Takayuki, K; Takeda, S; Takiguchi, M, 2022
)
3.61

Pharmacokinetics

Cannabidiol, Δ9-tetrahydrocannabinol, cannabinol, cannabichromene, and 5 specific metabolites were measured by liquid chromatography-tandem/mass-spectrometry. pharmacokinetic parameters were calculated.

ExcerptReferenceRelevance
" Cannabidiol, Δ9-tetrahydrocannabinol, cannabinol, cannabichromene, cannabigerol, cannabidiolic acid, cannabigerolic acid, Δ9-tetrahydrocannabinolic acid, and 5 specific metabolites were measured by liquid chromatography-tandem/mass-spectrometry, and pharmacokinetic parameters were calculated."( Twice-daily oral administration of a cannabidiol and cannabidiolic acid-rich hemp extract was well tolerated in orange-winged Amazon parrots (Amazona amazonica) and has a favorable pharmacokinetic profile.
Beaufrère, H; Gomez, B; Guzman, DS; Knych, H; Lyubimov, A; Sosa-Higareda, M; Zakharov, A, 2023
)
1.39
" For the multiple-dose study, cannabidiol/cannabidiolic acid mean Cmax was 337."( Twice-daily oral administration of a cannabidiol and cannabidiolic acid-rich hemp extract was well tolerated in orange-winged Amazon parrots (Amazona amazonica) and has a favorable pharmacokinetic profile.
Beaufrère, H; Gomez, B; Guzman, DS; Knych, H; Lyubimov, A; Sosa-Higareda, M; Zakharov, A, 2023
)
1.42
"The goal of pharmacokinetic (PK) studies is to provide a basis for appropriate dosing regimens with novel therapeutic agents."( A One Health perspective on comparative cannabidiol and cannabidiolic acid pharmacokinetics and biotransformation in humans and domestic animals.
Schwark, WS; Wakshlag, JJ, 2023
)
1.16

Dosage Studied

ExcerptRelevanceReference
" No changes in serum biochemistry analysis were observed following IH dosing compared to baseline values."( Plasma concentrations of eleven cannabinoids in cattle following oral administration of industrial hemp (Cannabis sativa).
Coetzee, JF; Curtis, A; Griffin, J; Kleinhenz, KE; Kleinhenz, MD; Lin, Z; Magnin, G; Martin, M; Montgomery, S, 2020
)
0.56
" Dose-response relationships were calculated using Probit analysis and statistical significance was assessed with a two-sample z-test."( Cannabidiolic acid exhibits entourage-like improvements of anticonvulsant activity in an acute rat model of seizures.
Beenhakker, M; Goerl, B; Metcalf, C; Smith, M; Watkins, S, 2021
)
2.06
" Test compounds should be compared by sub-chronic dosing in the MES test in order to assess safety and pharmacokinetic profiles."( Cannabidiolic acid exhibits entourage-like improvements of anticonvulsant activity in an acute rat model of seizures.
Beenhakker, M; Goerl, B; Metcalf, C; Smith, M; Watkins, S, 2021
)
2.06
" These data may be useful in determining appropriate dosing of cannabinoids in the domestic rabbit."( Feeding decreases the oral bioavailability of cannabidiol and cannabidiolic acid in hemp oil in New Zealand White rabbits (Oryctolagus cuniculus).
Carpenter, JW; Gardhouse, SM; KuKanich, B; Magnin, GC; Rooney, TA; Tully, TN, 2022
)
0.96
"The goal of pharmacokinetic (PK) studies is to provide a basis for appropriate dosing regimens with novel therapeutic agents."( A One Health perspective on comparative cannabidiol and cannabidiolic acid pharmacokinetics and biotransformation in humans and domestic animals.
Schwark, WS; Wakshlag, JJ, 2023
)
1.16
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (4)

ClassDescription
phytocannabinoidA class of cannabinoid which are C21 terpenophenolic compounds isolated primarily from Cannabis sativa.
resorcinolsAny benzenediol in which the two hydroxy groups are meta to one another.
polyketideNatural and synthetic compounds containing alternating carbonyl and methylene groups ('beta-polyketones'), biogenetically derived from repeated condensation of acetyl coenzyme A (via malonyl coenzyme A), and usually the compounds derived from them by further condensations, etc. Considered by many to be synonymous with the less frequently used terms acetogenins and ketides.
dihydroxybenzoic acidAny member of the class of hydroxybenzoic acids carrying two phenolic hydroxy groups on the benzene ring and its derivatives.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
CBD synthetic pathway08

Protein Targets (3)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
N-acylethanolamine-hydrolyzing acid amidaseHomo sapiens (human)IC50 (µMol)23.00000.70000.70000.7000AID1625159
Diacylglycerol lipase-alphaHomo sapiens (human)IC50 (µMol)19.40000.00101.05385.0119AID1625150
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Transient receptor potential cation channel subfamily A member 1Rattus norvegicus (Norway rat)EC50 (µMol)12.00000.06002.22238.4000AID482146
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (13)

Processvia Protein(s)Taxonomy
fatty acid metabolic processN-acylethanolamine-hydrolyzing acid amidaseHomo sapiens (human)
sphingosine metabolic processN-acylethanolamine-hydrolyzing acid amidaseHomo sapiens (human)
lipid catabolic processN-acylethanolamine-hydrolyzing acid amidaseHomo sapiens (human)
N-acylethanolamine metabolic processN-acylethanolamine-hydrolyzing acid amidaseHomo sapiens (human)
N-acylphosphatidylethanolamine metabolic processN-acylethanolamine-hydrolyzing acid amidaseHomo sapiens (human)
monoacylglycerol biosynthetic processDiacylglycerol lipase-alphaHomo sapiens (human)
G protein-coupled glutamate receptor signaling pathwayDiacylglycerol lipase-alphaHomo sapiens (human)
neuroblast proliferationDiacylglycerol lipase-alphaHomo sapiens (human)
arachidonic acid metabolic processDiacylglycerol lipase-alphaHomo sapiens (human)
diacylglycerol catabolic processDiacylglycerol lipase-alphaHomo sapiens (human)
retrograde trans-synaptic signaling by endocannabinoidDiacylglycerol lipase-alphaHomo sapiens (human)
regulation of neuroinflammatory responseDiacylglycerol lipase-alphaHomo sapiens (human)
cannabinoid biosynthetic processDiacylglycerol lipase-alphaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (10)

Processvia Protein(s)Taxonomy
hydrolase activity, acting on carbon-nitrogen (but not peptide) bondsN-acylethanolamine-hydrolyzing acid amidaseHomo sapiens (human)
N-acylsphingosine amidohydrolase activityN-acylethanolamine-hydrolyzing acid amidaseHomo sapiens (human)
fatty acid amide hydrolase activityN-acylethanolamine-hydrolyzing acid amidaseHomo sapiens (human)
N-(long-chain-acyl)ethanolamine deacylase activityN-acylethanolamine-hydrolyzing acid amidaseHomo sapiens (human)
ceramidase activityN-acylethanolamine-hydrolyzing acid amidaseHomo sapiens (human)
DNA-binding transcription factor bindingN-acylethanolamine-hydrolyzing acid amidaseHomo sapiens (human)
protein bindingDiacylglycerol lipase-alphaHomo sapiens (human)
metal ion bindingDiacylglycerol lipase-alphaHomo sapiens (human)
acylglycerol lipase activityDiacylglycerol lipase-alphaHomo sapiens (human)
lipoprotein lipase activityDiacylglycerol lipase-alphaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (12)

Processvia Protein(s)Taxonomy
cytoplasmN-acylethanolamine-hydrolyzing acid amidaseHomo sapiens (human)
lysosomeN-acylethanolamine-hydrolyzing acid amidaseHomo sapiens (human)
membraneN-acylethanolamine-hydrolyzing acid amidaseHomo sapiens (human)
lysosomal lumenN-acylethanolamine-hydrolyzing acid amidaseHomo sapiens (human)
extracellular exosomeN-acylethanolamine-hydrolyzing acid amidaseHomo sapiens (human)
plasma membraneDiacylglycerol lipase-alphaHomo sapiens (human)
early endosome membraneDiacylglycerol lipase-alphaHomo sapiens (human)
dendrite membraneDiacylglycerol lipase-alphaHomo sapiens (human)
dendritic spine membraneDiacylglycerol lipase-alphaHomo sapiens (human)
varicosityDiacylglycerol lipase-alphaHomo sapiens (human)
postsynaptic density membraneDiacylglycerol lipase-alphaHomo sapiens (human)
dendrite membraneDiacylglycerol lipase-alphaHomo sapiens (human)
cytoplasmDiacylglycerol lipase-alphaHomo sapiens (human)
postsynaptic membraneDiacylglycerol lipase-alphaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (58)

Assay IDTitleYearJournalArticle
AID1617287Ratio of drug level in anesthetized C57BL/6J mouse brain to plasma at 5 mg/kg, ip administered as single dose measured upto 240 mins in presence of vegetable oil by LC-MS/MS analysis2019Journal of natural products, 11-22, Volume: 82, Issue:11
Pharmacokinetics of Phytocannabinoid Acids and Anticonvulsant Effect of Cannabidiolic Acid in a Mouse Model of Dravet Syndrome.
AID1617295AUC in anesthetized C57BL/6J mouse plasma at 10 mg/kg, ip administered as single dose measured upto 240 mins in presence of tween-80 by LC-MS/MS analysis2019Journal of natural products, 11-22, Volume: 82, Issue:11
Pharmacokinetics of Phytocannabinoid Acids and Anticonvulsant Effect of Cannabidiolic Acid in a Mouse Model of Dravet Syndrome.
AID1625160Inhibition of recombinant human NAAA expressed in HEK293 cells at 100 uM using [14C]-N-palmitoylethanolamine as substrate measured after 30 mins by beta-counting method relative to control2019Journal of natural products, 03-22, Volume: 82, Issue:3
Plant-Based Modulators of Endocannabinoid Signaling.
AID1617279Cmax in anesthetized C57BL/6J mouse plasma at 10 mg/kg, ip administered as single dose measured upto 240 mins in presence of vegetable oil by LC-MS/MS analysis2019Journal of natural products, 11-22, Volume: 82, Issue:11
Pharmacokinetics of Phytocannabinoid Acids and Anticonvulsant Effect of Cannabidiolic Acid in a Mouse Model of Dravet Syndrome.
AID1617293Half life in anesthetized C57BL/6J mouse plasma at 10 mg/kg, ip administered as single dose measured upto 240 mins in presence of tween-80 by LC-MS/MS analysis2019Journal of natural products, 11-22, Volume: 82, Issue:11
Pharmacokinetics of Phytocannabinoid Acids and Anticonvulsant Effect of Cannabidiolic Acid in a Mouse Model of Dravet Syndrome.
AID362544Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 25923 after 18 hrs2008Journal of natural products, Aug, Volume: 71, Issue:8
Antibacterial cannabinoids from Cannabis sativa: a structure-activity study.
AID1617304Partition coefficient, log P of compound2019Journal of natural products, 11-22, Volume: 82, Issue:11
Pharmacokinetics of Phytocannabinoid Acids and Anticonvulsant Effect of Cannabidiolic Acid in a Mouse Model of Dravet Syndrome.
AID1825221Cytotoxicity against African green monkey Vero E6 cells by resazurin assay2022Journal of natural products, 01-28, Volume: 85, Issue:1
Cannabinoids Block Cellular Entry of SARS-CoV-2 and the Emerging Variants.
AID1825218Antiviral activity against SARS-CoV-2 isolate USA-WA1/2020 strain infected in African green monkey Vero E6 cells assessed as inhibition of viral entry incubated for 1 hr prior to infection and measured after 48 hrs by Focus forming assay2022Journal of natural products, 01-28, Volume: 85, Issue:1
Cannabinoids Block Cellular Entry of SARS-CoV-2 and the Emerging Variants.
AID1617275Half life in anesthetized C57BL/6J mouse plasma at 10 mg/kg, ip administered as single dose measured upto 240 mins by LC-MS/MS analysis2019Journal of natural products, 11-22, Volume: 82, Issue:11
Pharmacokinetics of Phytocannabinoid Acids and Anticonvulsant Effect of Cannabidiolic Acid in a Mouse Model of Dravet Syndrome.
AID1617278AUC in anesthetized C57BL/6J mouse brain at 10 mg/kg, ip administered as single dose measured upto 240 mins by LC-MS/MS analysis2019Journal of natural products, 11-22, Volume: 82, Issue:11
Pharmacokinetics of Phytocannabinoid Acids and Anticonvulsant Effect of Cannabidiolic Acid in a Mouse Model of Dravet Syndrome.
AID1782665Inhibition of human LDHB assessed as reduction in lactate production using pyruvate as substrate at 10 uM in presence of NADH by spectrophotometric analysis relative to control2021Journal of natural products, 05-28, Volume: 84, Issue:5
Cannabichromene and Δ
AID1825222Cytotoxicity against human Caco-2 cells by resazurin assay2022Journal of natural products, 01-28, Volume: 85, Issue:1
Cannabinoids Block Cellular Entry of SARS-CoV-2 and the Emerging Variants.
AID1625150Inhibition of recombinant human DAGLalpha expressed in COS7 cells using [14C]-oleoyl-2-arachidonoyl-glycerol as substrate measured after 20 mins by beta-counting method2019Journal of natural products, 03-22, Volume: 82, Issue:3
Plant-Based Modulators of Endocannabinoid Signaling.
AID1625159Inhibition of recombinant human NAAA expressed in HEK293 cells using [14C]-N-palmitoylethanolamine as substrate measured after 30 mins by beta-counting method2019Journal of natural products, 03-22, Volume: 82, Issue:3
Plant-Based Modulators of Endocannabinoid Signaling.
AID1625156Inhibition of FAAH in rat brain membranes using [14C]-AEA as substrate measured after 30 mins by scintillation counting method2019Journal of natural products, 03-22, Volume: 82, Issue:3
Plant-Based Modulators of Endocannabinoid Signaling.
AID1617276Half life in anesthetized C57BL/6J mouse brain at 10 mg/kg, ip administered as single dose measured upto 240 mins by LC-MS/MS analysis2019Journal of natural products, 11-22, Volume: 82, Issue:11
Pharmacokinetics of Phytocannabinoid Acids and Anticonvulsant Effect of Cannabidiolic Acid in a Mouse Model of Dravet Syndrome.
AID1617274Tmax in anesthetized C57BL/6J mouse brain at 10 mg/kg, ip administered as single dose measured upto 240 mins by LC-MS/MS analysis2019Journal of natural products, 11-22, Volume: 82, Issue:11
Pharmacokinetics of Phytocannabinoid Acids and Anticonvulsant Effect of Cannabidiolic Acid in a Mouse Model of Dravet Syndrome.
AID1617300Drug metabolism in brain of anesthetized C57BL/6J mouse at 10 mg/kg, ip by LC-MS/MS analysis2019Journal of natural products, 11-22, Volume: 82, Issue:11
Pharmacokinetics of Phytocannabinoid Acids and Anticonvulsant Effect of Cannabidiolic Acid in a Mouse Model of Dravet Syndrome.
AID1617307Anticonvulsant activity against hyperthermia-induced seizure in Scn1aRX/+ mouse model of Dravet syndrome assessed as increase in generalized tonic-clonic seizure temperature threshold at 10 to 30 mg/kg, ip administered as single dose measured by RET-3 rec2019Journal of natural products, 11-22, Volume: 82, Issue:11
Pharmacokinetics of Phytocannabinoid Acids and Anticonvulsant Effect of Cannabidiolic Acid in a Mouse Model of Dravet Syndrome.
AID1625155Inhibition of MAGL in African green monkey COS cell homogenates at 50 uM using [3H]-arachidonoylglycerol as substrate measured after 20 mins by scintillation counting method relative to control2019Journal of natural products, 03-22, Volume: 82, Issue:3
Plant-Based Modulators of Endocannabinoid Signaling.
AID362541Antibacterial activity against methicillin-resistant Staphylococcus aureus SA1199B after 18 hrs2008Journal of natural products, Aug, Volume: 71, Issue:8
Antibacterial cannabinoids from Cannabis sativa: a structure-activity study.
AID1625151Inhibition of recombinant human DAGLalpha expressed in COS7 cells at 50 uM using [14C]-oleoyl-2-arachidonoyl-glycerol as substrate measured after 20 mins by beta-counting method relative to control2019Journal of natural products, 03-22, Volume: 82, Issue:3
Plant-Based Modulators of Endocannabinoid Signaling.
AID1617291Tmax in anesthetized C57BL/6J mouse plasma at 10 mg/kg, ip administered as single dose measured upto 240 mins in presence of tween-80 by LC-MS/MS analysis2019Journal of natural products, 11-22, Volume: 82, Issue:11
Pharmacokinetics of Phytocannabinoid Acids and Anticonvulsant Effect of Cannabidiolic Acid in a Mouse Model of Dravet Syndrome.
AID1617288Ratio of drug level in anesthetized C57BL/6J mouse brain to plasma at 5 mg/kg, ip administered as single dose measured upto 240 mins in presence of tween-80 by LC-MS/MS analysis2019Journal of natural products, 11-22, Volume: 82, Issue:11
Pharmacokinetics of Phytocannabinoid Acids and Anticonvulsant Effect of Cannabidiolic Acid in a Mouse Model of Dravet Syndrome.
AID1617271Cmax in anesthetized C57BL/6J mouse plasma at 10 mg/kg, ip administered as single dose measured upto 240 mins by LC-MS/MS analysis2019Journal of natural products, 11-22, Volume: 82, Issue:11
Pharmacokinetics of Phytocannabinoid Acids and Anticonvulsant Effect of Cannabidiolic Acid in a Mouse Model of Dravet Syndrome.
AID1617281Tmax in anesthetized C57BL/6J mouse plasma at 10 mg/kg, ip administered as single dose measured upto 240 mins in presence of vegetable oil by LC-MS/MS analysis2019Journal of natural products, 11-22, Volume: 82, Issue:11
Pharmacokinetics of Phytocannabinoid Acids and Anticonvulsant Effect of Cannabidiolic Acid in a Mouse Model of Dravet Syndrome.
AID1617284Half life in anesthetized C57BL/6J mouse brain at 10 mg/kg, ip administered as single dose measured upto 240 mins in presence of vegetable oil by LC-MS/MS analysis2019Journal of natural products, 11-22, Volume: 82, Issue:11
Pharmacokinetics of Phytocannabinoid Acids and Anticonvulsant Effect of Cannabidiolic Acid in a Mouse Model of Dravet Syndrome.
AID1625157Inhibition of FAAH in rat brain membranes at 50 uM using [14C]-AEA as substrate measured after 30 mins by scintillation counting method relative to control2019Journal of natural products, 03-22, Volume: 82, Issue:3
Plant-Based Modulators of Endocannabinoid Signaling.
AID1617273Tmax in anesthetized C57BL/6J mouse plasma at 10 mg/kg, ip administered as single dose measured upto 240 mins by LC-MS/MS analysis2019Journal of natural products, 11-22, Volume: 82, Issue:11
Pharmacokinetics of Phytocannabinoid Acids and Anticonvulsant Effect of Cannabidiolic Acid in a Mouse Model of Dravet Syndrome.
AID1617286AUC in anesthetized C57BL/6J mouse brain at 10 mg/kg, ip administered as single dose measured upto 240 mins in presence of vegetable oil by LC-MS/MS analysis2019Journal of natural products, 11-22, Volume: 82, Issue:11
Pharmacokinetics of Phytocannabinoid Acids and Anticonvulsant Effect of Cannabidiolic Acid in a Mouse Model of Dravet Syndrome.
AID1625163Inhibition of [14C]-AEA uptake in rat RBL2H3 cells at 25 uM by scintillation counting method relative to control2019Journal of natural products, 03-22, Volume: 82, Issue:3
Plant-Based Modulators of Endocannabinoid Signaling.
AID1825216Antiviral activity against SARS-CoV-2 infected in African green monkey Vero E6 cells assessed as inhibition of viral entry at 25 ug/ml measured after 24 hrs post infection by fluorescence microscopy2022Journal of natural products, 01-28, Volume: 85, Issue:1
Cannabinoids Block Cellular Entry of SARS-CoV-2 and the Emerging Variants.
AID362542Antibacterial activity against macrolide-resistant Staphylococcus aureus RN4220 after 18 hrs2008Journal of natural products, Aug, Volume: 71, Issue:8
Antibacterial cannabinoids from Cannabis sativa: a structure-activity study.
AID362545Antibacterial activity against epidemic methicillin-resistant Staphylococcus aureus 15 after 18 hrs2008Journal of natural products, Aug, Volume: 71, Issue:8
Antibacterial cannabinoids from Cannabis sativa: a structure-activity study.
AID1625153Inhibition of MAGL in African green monkey COS cell homogenates using [3H]-arachidonoylglycerol as substrate measured after 20 mins by scintillation counting method2019Journal of natural products, 03-22, Volume: 82, Issue:3
Plant-Based Modulators of Endocannabinoid Signaling.
AID482146Agonist activity at rat TRPA1 channel expressed in HEK293 cells assessed as increase in intracellular calcium influx2010Journal of medicinal chemistry, Jul-22, Volume: 53, Issue:14
Transient receptor potential ankyrin 1 (TRPA1) channel as emerging target for novel analgesics and anti-inflammatory agents.
AID1617283Half life in anesthetized C57BL/6J mouse plasma at 10 mg/kg, ip administered as single dose measured upto 240 mins in presence of vegetable oil by LC-MS/MS analysis2019Journal of natural products, 11-22, Volume: 82, Issue:11
Pharmacokinetics of Phytocannabinoid Acids and Anticonvulsant Effect of Cannabidiolic Acid in a Mouse Model of Dravet Syndrome.
AID1617272Cmax in anesthetized C57BL/6J mouse brain at 10 mg/kg, ip administered as single dose measured upto 240 mins by LC-MS/MS analysis2019Journal of natural products, 11-22, Volume: 82, Issue:11
Pharmacokinetics of Phytocannabinoid Acids and Anticonvulsant Effect of Cannabidiolic Acid in a Mouse Model of Dravet Syndrome.
AID1617292Tmax in anesthetized C57BL/6J mouse brain at 10 mg/kg, ip administered as single dose measured upto 240 mins in presence of tween-80 by LC-MS/MS analysis2019Journal of natural products, 11-22, Volume: 82, Issue:11
Pharmacokinetics of Phytocannabinoid Acids and Anticonvulsant Effect of Cannabidiolic Acid in a Mouse Model of Dravet Syndrome.
AID1617294Half life in anesthetized C57BL/6J mouse brain at 10 mg/kg, ip administered as single dose measured upto 240 mins in presence of tween-80 by LC-MS/MS analysis2019Journal of natural products, 11-22, Volume: 82, Issue:11
Pharmacokinetics of Phytocannabinoid Acids and Anticonvulsant Effect of Cannabidiolic Acid in a Mouse Model of Dravet Syndrome.
AID1617280Cmax in anesthetized C57BL/6J mouse brain at 10 mg/kg, ip administered as single dose measured upto 240 mins in presence of vegetable oil by LC-MS/MS analysis2019Journal of natural products, 11-22, Volume: 82, Issue:11
Pharmacokinetics of Phytocannabinoid Acids and Anticonvulsant Effect of Cannabidiolic Acid in a Mouse Model of Dravet Syndrome.
AID1825217Antiviral activity against pseudovirus SARS-CoV-2 spike protein infected in HEK293T cells overexpressing ACE2 assessed as inhibition on pseudovirus infection incubated for 45 hrs by fluorescence microscopy2022Journal of natural products, 01-28, Volume: 85, Issue:1
Cannabinoids Block Cellular Entry of SARS-CoV-2 and the Emerging Variants.
AID1617282Tmax in anesthetized C57BL/6J mouse brain at 10 mg/kg, ip administered as single dose measured upto 240 mins in presence of vegetable oil by LC-MS/MS analysis2019Journal of natural products, 11-22, Volume: 82, Issue:11
Pharmacokinetics of Phytocannabinoid Acids and Anticonvulsant Effect of Cannabidiolic Acid in a Mouse Model of Dravet Syndrome.
AID1617277AUC in anesthetized C57BL/6J mouse plasma at 10 mg/kg, ip administered as single dose measured upto 240 mins by LC-MS/MS analysis2019Journal of natural products, 11-22, Volume: 82, Issue:11
Pharmacokinetics of Phytocannabinoid Acids and Anticonvulsant Effect of Cannabidiolic Acid in a Mouse Model of Dravet Syndrome.
AID1617270Ratio of drug level in anesthetized C57BL/6J mouse brain to plasma at 10 mg/kg, ip administered as single dose measured upto 240 mins by LC-MS/MS analysis2019Journal of natural products, 11-22, Volume: 82, Issue:11
Pharmacokinetics of Phytocannabinoid Acids and Anticonvulsant Effect of Cannabidiolic Acid in a Mouse Model of Dravet Syndrome.
AID362543Antibacterial activity against tetracycline-resistant Staphylococcus aureus XU212 after 18 hrs2008Journal of natural products, Aug, Volume: 71, Issue:8
Antibacterial cannabinoids from Cannabis sativa: a structure-activity study.
AID362546Antibacterial activity against epidemic methicillin-resistant Staphylococcus aureus 16 after 18 hrs2008Journal of natural products, Aug, Volume: 71, Issue:8
Antibacterial cannabinoids from Cannabis sativa: a structure-activity study.
AID1825219Antiviral activity against SARS-CoV-2 variant B.1.1.7 strain infected in African green monkey Vero E6 cells assessed as inhibition of viral entry incubated for 1 hr proir to infection and measured after 48 hrs by Focus forming assay2022Journal of natural products, 01-28, Volume: 85, Issue:1
Cannabinoids Block Cellular Entry of SARS-CoV-2 and the Emerging Variants.
AID1825223Cytotoxicity against human HEK293T cells overexpressing ACE2 by resazurin assay2022Journal of natural products, 01-28, Volume: 85, Issue:1
Cannabinoids Block Cellular Entry of SARS-CoV-2 and the Emerging Variants.
AID1617303Dissociation constant, pKa of compound2019Journal of natural products, 11-22, Volume: 82, Issue:11
Pharmacokinetics of Phytocannabinoid Acids and Anticonvulsant Effect of Cannabidiolic Acid in a Mouse Model of Dravet Syndrome.
AID1617285AUC in anesthetized C57BL/6J mouse plasma at 10 mg/kg, ip administered as single dose measured upto 240 mins in presence of vegetable oil by LC-MS/MS analysis2019Journal of natural products, 11-22, Volume: 82, Issue:11
Pharmacokinetics of Phytocannabinoid Acids and Anticonvulsant Effect of Cannabidiolic Acid in a Mouse Model of Dravet Syndrome.
AID1617299Drug uptake in plasma of anesthetized C57BL/6J mouse at 10 mg/kg, ip by LC-MS/MS analysis2019Journal of natural products, 11-22, Volume: 82, Issue:11
Pharmacokinetics of Phytocannabinoid Acids and Anticonvulsant Effect of Cannabidiolic Acid in a Mouse Model of Dravet Syndrome.
AID1617296AUC in anesthetized C57BL/6J mouse brain at 10 mg/kg, ip administered as single dose measured upto 240 mins in presence of tween-80 by LC-MS/MS analysis2019Journal of natural products, 11-22, Volume: 82, Issue:11
Pharmacokinetics of Phytocannabinoid Acids and Anticonvulsant Effect of Cannabidiolic Acid in a Mouse Model of Dravet Syndrome.
AID1825220Antiviral activity against SARS-CoV-2 variant B.1.351 strain infected in African green monkey Vero E6 cells assessed as inhibition of viral entry incubated for 1 hr prior to infection and measured after 48 hrs by Focus forming assay2022Journal of natural products, 01-28, Volume: 85, Issue:1
Cannabinoids Block Cellular Entry of SARS-CoV-2 and the Emerging Variants.
AID1625162Inhibition of [14C]-AEA uptake in rat RBL2H3 cells by scintillation counting method2019Journal of natural products, 03-22, Volume: 82, Issue:3
Plant-Based Modulators of Endocannabinoid Signaling.
AID1617290Cmax in anesthetized C57BL/6J mouse brain at 10 mg/kg, ip administered as single dose measured upto 240 mins in presence of tween-80 by LC-MS/MS analysis2019Journal of natural products, 11-22, Volume: 82, Issue:11
Pharmacokinetics of Phytocannabinoid Acids and Anticonvulsant Effect of Cannabidiolic Acid in a Mouse Model of Dravet Syndrome.
AID1617289Cmax in anesthetized C57BL/6J mouse plasma at 10 mg/kg, ip administered as single dose measured upto 240 mins in presence of tween-80 by LC-MS/MS analysis2019Journal of natural products, 11-22, Volume: 82, Issue:11
Pharmacokinetics of Phytocannabinoid Acids and Anticonvulsant Effect of Cannabidiolic Acid in a Mouse Model of Dravet Syndrome.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (76)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (1.32)18.7374
1990's1 (1.32)18.2507
2000's5 (6.58)29.6817
2010's32 (42.11)24.3611
2020's37 (48.68)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 33.85

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index33.85 (24.57)
Research Supply Index4.36 (2.92)
Research Growth Index5.78 (4.65)
Search Engine Demand Index44.85 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (33.85)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (1.32%)5.53%
Reviews6 (7.89%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other69 (90.79%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]